Wins 'BEST' Technology Award at the 2024 MEDITEK Innovation Awards

- Highly sensitive, label-free immuno-biosensor technology using electrochemically active nanoparticles -

Professor Jae-ho Shin from the Department of Chemistry has been recognized with the 'BEST' Technology award at the 2024 Meditech Innovation Awards (MEDITEK Innovation Awards).

Professor Jae-ho Shin receiving the award from President Jangho Chun (Photo: Kwangwoon University Industry-Academic Collaboration Foundation)

 The 2024 MEDITEK event is hosted by the MEDITEK Organizing Committee and co-organized by the Korea Association of University Technology Transfer Management, Korea Association of Technology Holdings, Korea Association of Research Institute Technology Transfer, Daegu-Gyeongbuk Medical Innovation Foundation, Osong Medical Innovation Foundation, Korea Innovation Foundation, and National Research Foundation of Korea. Held for the second consecutive year, the event attracted a large number of startups and universities with innovative technologies.

The MEDITEK Awards evaluate the technicality, product potential, and innovation of medical devices and healthcare-related technologies submitted by universities, hospitals, research institutions, startups, and SMEs. Of the 42 technologies recognized as 'Excellent,' 10 were selected as 'BEST.'

Professor Shin's technology, based on an aptamer-based, label-free rapid and accurate measurement technique, eliminates the need for a secondary aptamer, which is required in conventional sandwich-type immuno-biosensors. The high reliability and technical innovation of this sensor earned him the 'BEST' Technology award in the 'Diagnostics and Laboratory Equipment' category.

Professor Shin remarked, "This award-winning technology offers an original sensing platform that simplifies the measurement process while implementing a highly sensitive sensor. As a first-of-its-kind technology in the industry, it is expected to be applied across various immuno-biosensors detecting protein-based biomarkers (such as cancer, cardiovascular diseases, infectious diseases, and glycated hemoglobin), demonstrating its versatile potential."